We’re in a perfect storm of wealth building.
Here at InvestorPlace, we strive to make you a smarter investor by highlighting the trends and investing themes that can help make you rich.
The most fun we have is when several things come together and create a unique opportunity for our readers … when several of our principles combine to create a “perfect storm” for wealth building.
InvestorPlace – Stock Market News, Stock Advice & Trading Tips” data-reactid=”14″>InvestorPlace – Stock Market News, Stock Advice & Trading Tips
And we’ve got that going on right now.
Matt McCall’s “Jumper Stocks” anomaly.
This anomaly is, in part, how the marijuana company Cronos Group went from trading at $0.25 in July 2016 to $25.10 by January 2019. That’s a gain of more than 4,900% in less than three years.
This type of gain turns a $25k investment into more than $1.2M.
As a quick reminder, the idea is that as marijuana legalization continues and the plant is no longer scheduled as a controlled substance by the federal government, a unique opportunity will exist for marijuana companies to uplist – or “jump” – to the big exchanges such as the NYSE or NASDAQ.
It’s like being called up from the minor leagues to the major leagues – and a tremendous amount of money flows in its wake.
The pot stock jumpers Matt has identified combine some of our favorite wealth building themes:
- investing with tailwinds – marijuana
- finding the stocks no one else knows about – penny stocks
- getting in early – before they jump to a major exchange and explode in value
Circumstances don’t fall into place like that very often. So, when it happens, smart investors will want to take advantage.
Today, I want to describe why uplisting is can be so important for investors, and why jumper stocks provide a unique chance to rake in triple or quadruple digit gains.
Early Stage Investor issues that explain the benefits of uplisting, and how the criteria he uses to identify the winners can present investors who get in early.
U.S law has made life difficult for marijuana stocks, but some U.S.-based ancillary companies have jumped to the major stock exchanges and the investors in those stocks have reaped the benefits.
IIPR is a marijuana REIT that buys properties from medical marijuana growers that are already approved by their states. It then leases the property back to the growers. This arrangement gives the growers an infusion of cash, and IIPR gets regular rent payments under a long-term lease.
I’ll let Matt explain what happened next.
That’s a stunning return. In less than 2 months, up more than 38%!
Early Stage Investor.
Recent Comments